CDKN2D antibody
CDKN2D
Reactivity: Human, Mouse, Rat
WB, IHC, ELISA, IF
Host: Rabbit
Polyclonal
unconjugated
-
-
Target
See all CDKN2D Antibodies
-
CDKN2D
(Cyclin-Dependent Kinase Inhibitor 2D (p19, Inhibits CDK4) (CDKN2D))
-
Reactivity
-
Human, Mouse, Rat
-
Host
-
Rabbit
-
Clonality
-
Polyclonal
-
Conjugate
-
This CDKN2D antibody is un-conjugated
-
Application
-
Western Blotting (WB), Immunohistochemistry (IHC), ELISA, Immunofluorescence (IF)
-
Purification
-
Immunogen affinity purified
-
Purity
-
≥95 % as determined by SDS-PAGE
-
Immunogen
-
cyclin-dependent kinase inhibitor 2D(p19, inhibits CDK4)
-
Isotype
-
IgG
-
Top Product
-
Discover our top product CDKN2D Primary Antibody
-
-
-
Application Notes
-
WB: 1:500-1:2000, IHC: 1:20-1:200, IF: 1:20-1:200
-
Restrictions
-
For Research Use only
-
-
Format
-
Liquid
-
Buffer
-
PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,
-
Preservative
-
Sodium azide
-
Precaution of Use
-
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
-
-20 °C
-
Storage Comment
-
-20°C for 12 months (Avoid repeated freeze / thaw cycles.)
-
Expiry Date
-
12 months
-
-
Target
-
CDKN2D
(Cyclin-Dependent Kinase Inhibitor 2D (p19, Inhibits CDK4) (CDKN2D))
-
Alternative Name
-
p19 INK4d (CDKN2D Products)
-
Synonyms
-
ink4d antibody, p19 antibody, p19-ink4d antibody, CDKN2D antibody, ank2 antibody, INK4D antibody, p19-INK4D antibody, INK4d antibody, p19INK4d antibody, cyclin-dependent kinase inhibitor 2D S homeolog antibody, cyclin dependent kinase inhibitor 2D antibody, cyclin-dependent kinase inhibitor 2D antibody, Cyclin-dependent kinase 4 inhibitor D antibody, cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4) antibody, similar to cyclin-dependent kinase inhibitor 2D antibody, cdkn2d.S antibody, CDKN2D antibody, cdkn2d antibody, cdn2d antibody, Cdkn2d antibody
-
Background
-
Synonyms: Background:
-
Molecular Weight
-
16 kDa
-
UniProt
-
P55273
-
Pathways
-
Cell Division Cycle, Sensory Perception of Sound, Mitotic G1-G1/S Phases, Negative Regulation of intrinsic apoptotic Signaling
-